Exelixis, Inc.
USD51.98
+0.38 (+0.74%)
CEO
Michael Morrissey
IPO Date
2000-04-17
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$51.97
Prev. Close
$51.60
Day Low
$51.50
Day High
$52.34
52W Low
$33.76
52W High
$52.96
Market Cap
$13.07B
Volume
0.65M
| 9,812 |
| $50.14 |
| 29 May 2026 | PAPADOPOULOS STELIOS | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Heyman Tomas J. | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Eckhardt Sue Gail | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Smith Julie | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Freire Maria C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Beckerle Mary C | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | Oliver Bob | director | A-Award | Acquired | 8,367 | $0.00 |
| 29 May 2026 | WYSZOMIERSKI JACK L | director | A-Award | Acquired | 8,367 | $0.00 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Sale (Partial) | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |
| 27 Apr 2020 | Donna Shalala | Donna Shalala | Purchase | $1,001 - $15,000 |